WealthCare Investment Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$206K Hold
1,800
0.06% 184
2025
Q4
$296K Hold
1,800
0.09% 152
2025
Q3
$262K Hold
1,800
0.09% 151
2025
Q2
$229K Hold
1,800
0.08% 147
2025
Q1
$237K Hold
1,800
0.1% 135
2024
Q4
$257K Hold
1,800
0.11% 122
2024
Q3
$246K Hold
1,800
0.11% 122
2024
Q2
$227K Hold
1,800
0.11% 127
2024
Q1
$331K Hold
1,800
0.16% 99
2023
Q4
$318K Hold
1,800
0.17% 96
2023
Q3
$279K Hold
1,800
0.17% 91
2023
Q2
$250K Hold
1,800
0.15% 98
2023
Q1
$303K Hold
1,800
0.18% 93
2022
Q4
$305K Hold
1,800
0.21% 85
2022
Q3
$337K Hold
1,800
0.28% 76
2022
Q2
$292K Hold
1,800
0.25% 83
2022
Q1
$288K Hold
1,800
0.26% 82
2021
Q4
$477K Buy
+1,800
New +$485K 0.46% 51

Other funds holding RGEN

WealthCare Investment Partners's RGEN Position: Q1 2026 in Review

WealthCare Investment Partners held its Repligen (RGEN) position steady in Q1 2026 at 1,800 shares worth $206K. The position accounts for 0.06% of the portfolio, ranked #184.

WealthCare Investment Partners first reported a position in RGEN in Q4 2021 and has held it in 18 quarters since. The position peaked at $477K in Q4 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • WealthCare Investment Partners held 1,800 shares of Repligen worth $206K as of Q1 2026.
  • WealthCare Investment Partners left its Repligen share count unchanged in Q1 2026.
  • Repligen made up 0.06% of WealthCare Investment Partners's portfolio in Q1 2026, its #184 holding.
  • WealthCare Investment Partners first reported a position in Repligen in Q4 2021 and has held it in 18 quarters since.
  • WealthCare Investment Partners's Repligen position peaked at $477K in Q4 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on WealthCare Investment Partners's 13F filing for Q1 2026, filed 9 Apr 2026.